Patenting of life-saving drugs has created a global health crisis where human life has become a commercial commodity.
Millions of people—mostly in developing countries—lack access to life-saving drugs. Righting this imbalance is among the most important challenges of global public health of this century, argues Akansha Mehta. There is scant evidence to prove that frameworks for intellectual property rights and patent protection have benefited research, development and innovation in developing countries. When the laws of trade and commerce override the human […]